Epstein-barr Virus-associated Malignancies
📧 Sign up to get email alerts when something new happens for Epstein-barr Virus-associated Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors [Phase 1]
Phase 1 clinical study of a therapeutic immunological agent for Epstein-Barr virus-associated malignancies; currently active but not recruit…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: The Application of mRNA Immunotherapy Technology in Refractory Malignancies Associated With Epstein-Barr Virus (EBV) [NA]
This clinical trial update describes the use of mRNA immunotherapy to treat Epstein-Barr virus–associated malignancies, with the study curre…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors [Phase 1]
Phase 1 clinical trial evaluating an mRNA immunotherapy for Epstein-Barr virus–related refractory malignant tumors; the study is active but …